Genmab A/S
GMAB | NASDAQ
$34.69
-$0.05 (-0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$34.44
-$0.25 (-0.72%)
Pre-market:
Sep 22, 2026, 8:10 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 19.91 | 12.39 | 32.56 | 35.29 | 57.22 | 33.93 |
PEG Ratio | -0.23 | 0.15 | -1.56 | 0.42 | -1.50 | 0.30 |
PS Ratio | 5.14 | 4.51 | 8.60 | 13.27 | 20.09 | 15.96 |
PB Ratio | 3.28 | 2.65 | 4.48 | 7.05 | 7.62 | 8.44 |
P/FCF Ratio | 16.65 | 12.81 | 20.23 | 53.53 | 85.59 | 26.35 |
P/OCF Ratio | 16.13 | 12.50 | 19.20 | 49.20 | 75.91 | 25.09 |
OCF/S Ratio | 31.88 | 36.10 | 44.80 | 26.97 | 26.47 | 63.62 |
Debt / Equity Ratio | 0.93 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
Quick Ratio | 2.01 | 5.24 | 13.32 | 15.48 | 14.50 | 15 |
Current Ratio | 2.02 | 5.25 | 13.34 | 15.48 | 14.50 | 15 |
Asset Turnover | 0.29 | 0.47 | 0.47 | 0.48 | 0.34 | 0.48 |
Interest Coverage | 20.49 | 55.86 | 197.07 | 298.43 | 227.15 | 631.30 |
Return on Equity | 16.52% | 21.38% | 13.77% | 19.98% | 13.32% | 24.88% |
Return on Assets | 7.50% | 17.12% | 12.33% | 18.10% | 12.01% | 22.50% |
Return on Invested Capital | 8.54% | 14.13% | 12.49% | 17.34% | 9.64% | 25.52% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 91.69% | 95.42% | 98.63% | 100% | 100% | 100% |
Net Profit Margin | 25.89% | 36.44% | 26.42% | 37.59% | 35.13% | 47.06% |
Pretax Profit Margin | 32.37% | 42.57% | 34.22% | 47.88% | 46.55% | 58.39% |
Operating Profit Margin | 33.60% | 31.14% | 32.30% | 43.21% | 35.08% | 62.44% |
FCF Margin | 30.89% | 35.23% | 42.52% | 24.78% | 23.48% | 60.59% |
EBITDA Margin | 35.91% | 45.05% | 36.10% | 50.64% | 49.67% | 60.92% |
Add to Watchlist
Select watchlists to add or remove GMAB